Pure recombinant peptide hormone , manufactured under strict GMP standards
These criteria help researchers focus on individuals who may benefit most from GLP-1 medications
No debe usarse si tienes antecedentes personales o familiares de carcinoma medular de tiroides o sndrome de neoplasia endocrina mltiple tipo 2
these warrant urgent TSH recheck and possible dose correction
KFF, Medicaid Coverage of and Spending on GLP-1s, 2026 Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and for cardiovascular risk reduction in adults with established CVD it is not a diabetes drug and cannot be routed through a diabetes benefit
OR11-01 efficacy and safety of setmelanotide in acquired hypothalamic obesity: results from a double-blind, multicenter, placebo-controlled, randomized phase 3 trial